NCT00068549View on ClinicalTrials.gov

Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2008

Conditions
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell CarcinomaStage IB Cervical CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage IVA Cervical Cancer
Interventions
DRUG

Gemcitabine Hydrochloride

Given IV

DRUG

Cisplatin

Given IV

RADIATION

Radiation Therapy

Undergo whole pelvis radiotherapy

RADIATION

Internal Radiation Therapy

Undergo brachytherapy

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00068549 - Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | Biotech Hunter | Biotech Hunter